INDICATIONS
I. Medical Card System, Inc., (MCS) will consider medically necessary Stereotactic Radiosurgery (SRS) & Stereotactic Body Radiation Therapy (SBRT) for cranial lesions for any of the following indications:
1. Primary central nervous system malignancies, generally under 5 cm and as a boost treatment for larger cranial, base of skull, or spinal lesions that have been treated initially with external beam radiation therapy or surgery (i.e., grade III and IV gliomas, oligodendrogliomas, sarcomas, chondrosarcomas, chordomas, and nasopharyngeal or paranasal sinus malignancies).
2. Primary and secondary tumors involving the brain or spine parenchyma, meninges/dura, or immediately adjacent boney structures. 7. Relapse in a previously irradiated cranial or spinal field where the additional stereotactic precision is required to avoid unacceptable vital tissue radiation.
8. Other cranial non-neoplastic conditions for which it has been proven effective, e.g., movement disorders such as Parkinson's disease, essential tremor and other disabling tremor that are refractory to conventional therapy, such as severe, sustained trigeminal neuralgia not responsive to other modalities.
II. Medical Card System, Inc., (MCS) will consider medically necessary Stereotactic Body Radiation Therapy (SBRT) medically necessary for certain conditions as long as the following criteria's are met:
2. When there is a reason to believe that doses generally thought to be above the level otherwise attainable with other methods might improve control rates.
3. In circumstances when the higher levels of precision associated with SBRT as compared to other radiation methods are necessary, i.e., clinically relevant
Either criteria 4 or 5 must be present:
4. For the treatment of primary lesions, the intent of treatment must be curative with the exception of lesions within the pancreas or liver.
5. For the treatment of metastatic lesions, there must be:
 The expectation of a long-term benefit (> 6 months) that could not have been attained with conventional therapy  The expectation of a complete eradication of the metastatic lesion that could not have been safely accomplished with conventional therapy, as evidenced by a dosimetric advantage for SBRT over other forms of radiation therapy.
Criteria #6 MUST always be present:
6. The patient's record demonstrates why SBRT is considered the treatment of choice for the individual patient. Specifically, the record must address the lower risk to normal tissue, the lower risk of disease recurrence, and the advantages of the treatment over, conventional radiation therapy, IMRT or 3-dimensional conformal radiation. Dosimetric evidence of reduced normal tissue toxicity and/or improved tumor control must be maintained.
III.
Medical Card System, Inc., (MCS) will consider SBRT medically necessary ONLY if the above criteria are met as specified for the following conditions: 3 Malignant Neoplasm Of Ethmoidal Sinus 160. 4 Malignant Neoplasm Of Frontal Sinus 160. 5 Malignant Neoplasm Of Sphenoidal Sinus 160. 8 Malignant Neoplasm Of Other Accessory Sinuses 160. 9 Malignant 3 Benign Neoplasm Of Spinal Cord 225. 4 Benign Neoplasm Of Spinal Meninges 227. 3 Benign Neoplasm Of Pituitary Gland And Craniopharyngeal Duct (Pouch) 227. 4 Benign Neoplasm Of Pineal Gland 227. 6 Benign 
ICD-10 Codes (Preview Draft)
In preparation for changes in the coding systems form ICD-9 to ICD -10, this policy includes a sample list of ICD-10 codes for your reference. These codes may become subject to changes or modifications since they will be in effect on October 1, 2014.
These are the only covered ICD-10 CM codes that support medical necessity under this policy for procedure codes 77371, 77372, 77373, G0339 and G0340 for SRS:
ICD-10-Codes DESCRIPTION

C11.0
Malignant neoplasm of superior wall of nasopharynx C11. 1 Malignant neoplasm of posterior wall of nasopharynx C11. 2 Malignant neoplasm of lateral wall of nasopharynx C11. 3 Malignant neoplasm of anterior wall of nasopharynx C11. 8 Malignant neoplasm of overlapping sites of nasopharynx C11. 9 Malignant neoplasm of nasopharynx, unspecified C30. 1 Malignant neoplasm of middle ear C31.0
Malignant neoplasm of maxillary sinus C31. 1 Malignant neoplasm of ethmoidal sinus C31. 2 Malignant neoplasm of frontal sinus C31. 3 Malignant neoplasm of sphenoid sinus C31. 8 Malignant neoplasm of overlapping sites of accessory sinuses
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C31.9
Malignant neoplasm of accessory sinus, unspecified C41. 2 Malignant neoplasm of vertebral column C69. 40 Malignant neoplasm of unspecified ciliary body C69. 41 Malignant neoplasm of right ciliary body C69. 42 Malignant neoplasm of left ciliary body C69. 60 Malignant neoplasm of unspecified orbit C69. 61 Malignant neoplasm of right orbit C69. 62 Malignant neoplasm of left orbit C69. 50 Malignant neoplasm of unspecified lacrimal gland and duct C69. 00 Malignant neoplasm of unspecified conjunctiva C69. 01 Malignant neoplasm of right conjunctiva C69. 02 Malignant neoplasm of left conjunctiva C69. 10 Malignant neoplasm of unspecified cornea C69. 11 Malignant neoplasm of right cornea C69. 12 Malignant neoplasm of left cornea C69. 20 Malignant neoplasm of unspecified retina C69. 21 Malignant neoplasm of right retina C69. 22 Malignant neoplasm of left retina C69. 30 Malignant neoplasm of unspecified choroid C69. 31 Malignant neoplasm of right choroid C69. 32 Malignant neoplasm of left choroid C69. 50 Malignant neoplasm of unspecified lacrimal gland and duct C69. 51 Malignant neoplasm of right lacrimal gland and duct C69. 52 Malignant neoplasm of left lacrimal gland and duct C69. 80 Malignant neoplasm of overlapping sites of unspecified eye and adnexa C69. 81 Malignant neoplasm of overlapping sites of right eye and adnexa C69. 82 Malignant neoplasm of overlapping sites of left eye and adnexa C69. 90 Malignant neoplasm of unspecified site of unspecified eye C69. 91 Malignant neoplasm of unspecified site of right eye C69. 92 Malignant neoplasm of unspecified site of left eye C71.0
Malignant neoplasm of cerebrum, except lobes and ventricles C71. 1 Malignant neoplasm of frontal lobe C71. 2 Malignant neoplasm of temporal lobe C71. 3 Malignant neoplasm of parietal lobe C71. 4 Malignant neoplasm of occipital lobe C71. 5 Malignant neoplasm of cerebral ventricle C71. 6 Malignant neoplasm of cerebellum
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C71.7
Malignant neoplasm of brain stem C71. 8 Malignant neoplasm of overlapping sites of brain C71. 9 Malignant neoplasm of brain, unspecified C72. 20 Malignant neoplasm of unspecified olfactory nerve C72. 21 Malignant neoplasm of right olfactory nerve C72. 22 Malignant neoplasm of left olfactory nerve C72. 30 Malignant neoplasm of unspecified optic nerve C72. 31 Malignant neoplasm of right optic nerve C72. 32 Malignant neoplasm of left optic nerve C72. 40 Malignant neoplasm of unspecified acoustic nerve C72. 41 Malignant neoplasm of right acoustic nerve C72. 42 Malignant neoplasm of left acoustic nerve C72. 50 Malignant neoplasm of unspecified cranial nerve C72. 59 Malignant neoplasm of other cranial nerves C70.0
Malignant neoplasm of cerebral meninges C70. 9 Malignant neoplasm of meninges, unspecified C70. 1 Malignant neoplasm of spinal meninges C75. 1 Malignant neoplasm of pituitary gland C75. 2 Malignant neoplasm of craniopharyngeal duct C75. 3 Malignant neoplasm of pineal gland C75. 5 Malignant neoplasm of aortic body and other paraganglia C79. 31 Secondary malignant neoplasm of brain C79. 32 Secondary malignant neoplasm of cerebral meninges C79. 40 Secondary malignant neoplasm of unspecified part of nervous system C79. 49 Secondary malignant neoplasm of other parts of nervous system C79. 51 Secondary malignant neoplasm of bone C79. 52 Secondary malignant neoplasm of bone marrow C79. 89 Secondary malignant neoplasm of other specified sites C79. 9 Secondary malignant neoplasm of unspecified site D16. 6 Benign neoplasm of vertebral column D33.0
Benign neoplasm of brain, supratentorial D33. 1 Benign neoplasm of brain, infratentorial D33. 2 Benign neoplasm of brain, unspecified D33. 3 Benign neoplasm of cranial nerves D32.0
Benign neoplasm of cerebral meninges D32. 9 Benign neoplasm of meninges, unspecified D33. 4 Benign neoplasm of spinal cord
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D32.1
Benign neoplasm of spinal meninges D35. 2 Benign neoplasm of pituitary gland D35. 3 Benign neoplasm of craniopharyngeal duct D35. 4 Benign neoplasm of pineal gland D35. 6 Benign neoplasm of aortic body and other paraganglia D18. 02 Hemangioma of intracranial structures D09. 3 Carcinoma in situ of thyroid and other endocrine glands D09. 8 Carcinoma in situ of other specified sites D44. 3 Neoplasm of uncertain behavior of pituitary gland D44. 4 Neoplasm of uncertain behavior of craniopharyngeal duct D44. 5 Neoplasm of uncertain behavior of pineal gland D44. 6 Neoplasm of uncertain behavior of carotid body D44. 7 Neoplasm of uncertain behavior of aortic body and other paraganglia D43.0
Neoplasm of uncertain behavior of brain, supratentorial D43. 1 Neoplasm of uncertain behavior of brain, infratentorial D43. 2 Neoplasm of uncertain behavior of brain, unspecified D43. 4 Neoplasm of uncertain behavior of spinal cord D42.0
Neoplasm of uncertain behavior of cerebral meninges D42. 1 Neoplasm of uncertain behavior of spinal meninges D42. 9 Neoplasm of uncertain behavior of meninges, unspecified D49. 6 Neoplasm of unspecified behavior of brain D49. 7 Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system
E27.0 Other adrenocortical overactivity G20
Parkinson's disease G21. 4 Vascular parkinsonism G25.0
Essential tremor G25. 1 Drug-induced tremor G25. 2 Other specified forms of tremor G50.0
Trigeminal neuralgia G50. 8 Other disorders of trigeminal nerve G51. 1 Geniculate ganglionitis G51. 2 Melkersson's syndrome G51. 3 Clonic hemifacial spasm G51. 4 Facial myokymia G51. 8 Other disorders of facial nerve G51. 9 Disorder of facial nerve, unspecified
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G52.0
Disorders of olfactory nerve G52. 1 Disorders of glossopharyngeal nerve G52. 1 Disorders of glossopharyngeal nerve G52. 2 Disorders of vagus nerve G52. 8 Disorders of other specified cranial nerves G52. 3 Disorders of hypoglossal nerve G52. 7 Disorders of multiple cranial nerves G52. 9 Cranial nerve disorder, unspecified G53
Cranial nerve disorders in diseases classified elsewhere Q28. 2 Arteriovenous malformation of cerebral vessels Q28. 3 Other malformations of cerebral vessels Q27. 9 Congenital malformation of peripheral vascular system, unspecified Malignant neoplasm of posterior wall of nasopharynx C11. 2 Malignant neoplasm of lateral wall of nasopharynx C11. 3 Malignant neoplasm of anterior wall of nasopharynx C11. 8 Malignant neoplasm of overlapping sites of nasopharynx C11. 9 Malignant neoplasm of nasopharynx, unspecified C22.0
Liver cell carcinoma C22. 2 Hepatoblastoma C22. 3 Angiosarcoma of liver C22. 4 Other sarcomas of liver C22. 7 Other specified carcinomas of liver C22. 8 Malignant neoplasm of liver, primary, unspecified as to type C22. 1 Intrahepatic bile duct carcinoma C22. 9 Malignant neoplasm of liver, not specified as primary or secondary C25.0
Malignant neoplasm of head of pancreas C25. 1 Malignant neoplasm of body of pancreas C25. 2 Malignant neoplasm of tail of pancreas C25. 3 Malignant neoplasm of pancreatic duct C25. 4 Malignant neoplasm of endocrine pancreas
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C25.7
Malignant neoplasm of other parts of pancreas C25. 8 Malignant neoplasm of overlapping sites of pancreas C25. 9 Malignant neoplasm of pancreas, unspecified C33 Malignant neoplasm of trachea C34. 00 Malignant neoplasm of unspecified main bronchus C34. 01 Malignant neoplasm of right main bronchus C34. 02 Malignant neoplasm of left main bronchus C34. 10 Malignant neoplasm of upper lobe, unspecified bronchus or lung C34. 11 Malignant neoplasm of upper lobe, right bronchus or lung C34. 12 Malignant neoplasm of upper lobe, left bronchus or lung C34. 2 Malignant neoplasm of middle lobe, bronchus or lung C34. 30 Malignant neoplasm of lower lobe, unspecified bronchus or lung C34. 31 Malignant neoplasm of lower lobe, right bronchus or lung C34. 32 Malignant neoplasm of lower lobe, left bronchus or lung C34. 80 Malignant neoplasm of overlapping sites of unspecified bronchus and lung C34. 81 Malignant neoplasm of overlapping sites of right bronchus and lung C34. 82 Malignant neoplasm of overlapping sites of left bronchus and lung C34. 90 Malignant neoplasm of unspecified part of unspecified bronchus or lung C34. 91 Malignant neoplasm of unspecified part of right bronchus or lung C34. 92 Malignant neoplasm of unspecified part of left bronchus or lung C64. 1 Malignant neoplasm of right kidney, except renal pelvis C64. 2 Malignant neoplasm of left kidney, except renal pelvis C64. 9 Malignant neoplasm of unspecified kidney, except renal pelvis C65. 1 Malignant neoplasm of right renal pelvis C65. 2 Malignant neoplasm of left renal pelvis C65. 9 Malignant neoplasm of unspecified renal pelvis C74. 00 Malignant neoplasm of cortex of unspecified adrenal gland C74. 01 Malignant neoplasm of cortex of right adrenal gland C74. 02 Malignant neoplasm of cortex of left adrenal gland C74. 10 Malignant neoplasm of medulla of unspecified adrenal gland C74. 11 Malignant neoplasm of medulla of right adrenal gland C74. 12 Malignant neoplasm of medulla of left adrenal gland C74. 90 Malignant neoplasm of unspecified part of unspecified adrenal gland C74. 91 Malignant neoplasm of unspecified part of right adrenal gland C74. 92 Malignant neoplasm of unspecified part of left adrenal gland C78. 00 Secondary malignant neoplasm of unspecified lung C78. 01 Secondary malignant neoplasm of right lung
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C78.02
Secondary malignant neoplasm of left lung C78. 7 Secondary malignant neoplasm of liver and intrahepatic bile duct C78. 80 Secondary malignant neoplasm of unspecified digestive organ C78. 89 Secondary malignant neoplasm of other digestive organs C79. 00 Secondary malignant neoplasm of unspecified kidney and renal pelvis C79. 01 Secondary malignant neoplasm of right kidney and renal pelvis C79. 02 Secondary malignant neoplasm of left kidney and renal pelvis C79. 31 Secondary malignant neoplasm of brain C79. 32 Secondary malignant neoplasm of cerebral meninges C79. 40 Secondary malignant neoplasm of unspecified part of nervous system C79. 49 Secondary malignant neoplasm of other parts of nervous system C79. 51 Secondary malignant neoplasm of bone
C79.89
Secondary malignant neoplasm of other specified sites C79. 9 Secondary malignant neoplasm of unspecified site D35. 6 Benign neoplasm of aortic body and other paraganglia D09. 3 Carcinoma in situ of thyroid and other endocrine glands D09. 8 Carcinoma in situ of other specified sites D44. 6 Neoplasm of uncertain behavior of carotid body D44. 7 Neoplasm of uncertain behavior of aortic body and other paraganglia D49. 7 Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system
